noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Destination DC

DC remains open for travel during federal government shutdown
United States Bankruptcy Court for[...]

PUBLIC NOTICE: Appointment of Assistant U.S. Bankruptcy Administrator
The Office of the Governor of the[...]

Governor Phil Scott Announces $3 Million in Downtown and Village Center[...]

Healthcare

Johnson & Johnson

10/16/2025 | Press release | Distributed by Public on 10/16/2025 06:03

Johnson & Johnson receives U.S. FDA Priority Review for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) in BRCA-mutated metastatic castration-sensitive prostate[...]

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Johnson & Johnson published this content on October 16, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 16, 2025 at 12:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back